{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:48:35Z","timestamp":1740134915902,"version":"3.37.3"},"reference-count":10,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5,4]]},"DOI":"10.1182\/blood.2023019714","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T16:41:27Z","timestamp":1691080887000},"page":"2167-2168","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Immediate COVID-19 treatment in CLL"],"prefix":"10.1182","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9880-5242","authenticated-orcid":false,"given":"Carsten Utoft","family":"Niemann","sequence":"first","affiliation":[{"name":"1Rigshospitalet, Copenhagen University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"18","key":"2023080316405225400_bib1","first-page":"2239","article-title":"Effectiveness of nirmatrelvir plus ritonavir treatment for patients with chronic lymphocytic leukemia during the Omicron surge","volume":"141","author":"Tadmor","year":"2023","journal-title":"Blood"},{"issue":"2","key":"2023080316405225400_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/blood.2022018283","article-title":"Efficacy of tixagevimabcilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies","volume":"141","author":"Davis","year":"2023","journal-title":"Blood"},{"issue":"5","key":"2023080316405225400_bib3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1182\/blood.2022016147","article-title":"Patients with CLL have a lower risk of death from COVID-19 in the Omicron era","volume":"140","author":"Niemann","year":"2022","journal-title":"Blood"},{"key":"2023080316405225400_bib4","article-title":"Vurdering af risiko for d\u00f8d og indl\u00e6ggelse hos SARS-CoV-2 inficerede patienter med malign h\u00e6matologisk sygdom\u20132","author":"Helleberg","year":"2022","journal-title":"SSI.dk"},{"issue":"11","key":"2023080316405225400_bib5","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.1038\/bcj.2016.105","article-title":"Improved survival for patients diagnosed with chronic lymphocytic leukemia in the\u00a0era\u00a0of chemo-immunotherapy: a Danish\u00a0population-based study of 10455 patients","volume":"6","author":"da Cunha-Bang","year":"2016","journal-title":"Blood Cancer J"},{"issue":"suppl 1","key":"2023080316405225400_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2021-146161","article-title":"A randomized phase III study of venetoclax-based time-limited combination treatments (RVe, GVe, GIVe) vs standard chemoimmunotherapy (CIT: FCR\/BR) in frontline chronic lymphocytic leukemia (CLL) of fit patients: first co-primary endpoint analysis of the International Intergroup GAIA (CLL13) Trial [abstract]","volume":"138","author":"Eichhorst","year":"2021","journal-title":"Blood"},{"issue":"suppl 1","key":"2023080316405225400_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood-2022-156070","article-title":"Residual disease kinetics among patients with high-risk factors treated with first-line fixed-duration ibrutinib plus venetoclax (Ibr+Ven) versus chlorambucil plus obinutuzumab (Clb+O): the Glow Study [abstract]","volume":"140","author":"Niemann","year":"2022","journal-title":"Blood"},{"issue":"9","key":"2023080316405225400_bib8","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1038\/s41375-021-01156-x","article-title":"Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death","volume":"35","author":"Rotbain","year":"2021","journal-title":"Leukemia"},{"issue":"1","key":"2023080316405225400_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/bloodadvances.2022008073","article-title":"Interventions to reduce infections in patients with hematological malignancies: a systematic review and meta-analysis","volume":"7","author":"Chai","year":"2023","journal-title":"Blood Adv"},{"issue":"1","key":"2023080316405225400_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41467-019-14225-8","article-title":"Machine learning can identify newly diagnosed patients with CLL at high risk\u00a0of\u00a0infection","volume":"11","author":"Agius","year":"2020","journal-title":"Nat Commun"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/141\/18\/2167\/2068900\/blood_bld-2023-019714-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/141\/18\/2167\/2068900\/blood_bld-2023-019714-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T16:41:37Z","timestamp":1691080897000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/141\/18\/2167\/495493\/Immediate-COVID-19-treatment-in-CLL"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":10,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023,5,4]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023019714","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"type":"print","value":"0006-4971"},{"type":"electronic","value":"1528-0020"}],"subject":[],"published":{"date-parts":[[2023,5,4]]}}}